# A Path to Preventing Cognitive Impairment Due to Alzheimer's Disease Page: https://stenobird.com/podcast/neurology-minute-15117/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-s-disease Text version: https://stenobird.com/podcast/neurology-minute-15117/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-s-disease.md Podcast: [Neurology Minute](https://stenobird.com/podcast/neurology-minute-15117) Published: 2026-04-16T08:30:00+00:00 Episode link: https://neurologyminute.libsyn.com/a-path-to-preventing-cognitive-impairment-due-to-alzheimers-disease Audio file: https://traffic.libsyn.com/secure/neurologyminute/04_April_16th_2026_nm_v2_1.mp3?dest-id=1085030 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/neurology-minute-15117/episodes/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-s-disease Duration seconds: 122 ## Resource Dr. Greg Cooper and Dr. Eric Reiman discuss emerging antibody therapies for preclinical Alzheimer's disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care. Show citation: Reiman EM, Alexander RC, Langbaum JB, et al. A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA. Lancet Neurol . 2026;25(3):268-278. doi: 10.1016/S1474-4422(25)00483-1 ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/neurology-minute-15117/episodes/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-s-disease/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/neurology-minute-15117/a-path-to-preventing-cognitive-impairment-due-to-alzheimer-s-disease.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.